Clinical trial
Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at…
NCT00238316 · NCIC Clinical Trials Group, Other · Completed
Key facts
| NCT number | NCT00238316 |
|---|---|
| Title | Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast Density |
| Official title | A Randomized Feasibility Study of Letrozole in Postmenopausal Women at Increased Risk for Development of Breast Cancer as Evidenced by High Breast Density |
| Lead sponsor | NCIC Clinical Trials Group, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Other |
| Interventions | letrozole, Placebo |
| Enrollment | 68 |
| Start date | Dec 5, 2000 |
| Primary completion | Nov 16, 2007 |
| Completion | Feb 10, 2009 |
| First posted | Oct 13, 2005 |
| Last update posted | Apr 2, 2020 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: